Obesity and metabolic syndrome are associated with short-term endocrine therapy resistance in early ER + breast cancer.

Our findings suggest the association between obesity/metabolic syndrome and breast cancer recurrence is better reflected by response to treatment than tumor-intrinsic properties, suggesting interventions to reverse obesity and/or MS may improve outcomes for breast cancer recurrence.